Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Reduced Left Ventricular Ejection Fraction
To the Editor:
Chaliki et al 1 have presented data in patients with severe aortic regurgitation (AR) with normal left ventricular (LV) ejection fraction (LVEF Ն50%; nϭՆ73). "Mild" LVEF reduction (35% to 50%; nϭ134) and "markedly" low LVEF (Ͻ35%; nϭ43) who were operated on between 1980 and 1995.
In February of 1980, 2 we documented (in a study not cited by the authors) the outcome of 17 patients with severe AR and LVEF of 0.25 to 0.49 who had aortic valve replacement (AVR) between January 1973 and July 1977. There were no operative deaths. There were 5 late deaths, and of the remaining 12 patients, 5 and 6 were in New York Heart Association functional classes II and I, respectively. We concluded that all patients with severe AR and moderately severe impairment of LV function should be offered AVR with or without coronary artery bypass graft unless there is a specific contraindication to surgery because of the low operative mortality and the improvement in symptoms and in various parameters of LV size and function after AVR.
Of interest, the conclusion of Chaliki and coworkers 1 in 2002 that such patients "should not be denied the benefits of AVR" is not different from ours in 1980.
The findings of Chaliki et al 1 would be more valuable clinically if the following were provided:
(1) The number and percentage of patients in each of the 3 subgroups who had preoperative coronary arteriography, and of these, the number and percentage who had significantly obstructive coronary artery disease.
(2) The numbers of patients with LVEF 20% to Ͻ25% and 15% to Ͻ20%, and their operative mortality and survival (meanϮSE) at 3, 5, 10, and 20 years.
(3) Actuarial event-free survival (including operative mortality and all complications including those related to the prosthesis and to cardiac and noncardiac comorbid conditions) at 5 and 10 years (mean Ϯ SE) in the subgroup of markedly low LVEF; the authors state that "a notable period of event-free survival can be achieved in most patients after correction of AR despite their very low preoperative EF," but actuarial event-free survival data were not presented.
Their finding of the higher than "expected" late mortality (Figure 2 1 ) is problematic because operative mortality was excluded, and the comparison to the population is inappropriate in this instance.
Shahbudin H. Rahimtoola, MB, FRCP Division of Cardiology Keck School of Medicine University of Southern California
Los Angeles, California 
Response
We appreciate Dr Rahimtoola's interest in our publication on aortic regurgitation (AR) with markedly reduced function. 1 His previous publication 2 could not be referenced because of space limitations, but it raises important points regarding dangers of small "outcome" studies. That study 2 analyzed 17 patients operated on in the 1970s; no operative deaths were reported. In contrast, there was clearly an excess operative mortality in our study 1 in those 177 patients with AR and ejection fraction (EF) Ͻ50%. In addition, Dr Rahimtoola's prior study 2 had short follow-up, deaths (2) related to lack of anticoagulation, and sample limited to 4 patients with EF Ͻ35%, which limited conclusions on outcome. We believe studies with a larger sample size and long follow-up such as ours 1 (450 patients and a median follow-up of 8.1 years) are the key to sound outcome analysis. Dr Rahimtoola's questions are addressed below.
(1) Of 370 patients (82%) with preoperative angiography, 98 (22%) had hemodynamically significant coronary artery disease (CAD). Patients without preoperative angiography were younger (43 versus 60 years old, PϽ0.0001), suggesting a low likelihood of CAD. Importantly, the adjusted hazard ratio for postoperative survival of low EF (Ͻ35%) versus normal EF (Ն 50%) was 2.4 (1.5 to 3.7, PϽ0.001) overall and was similar, 2.75 (1.5 to 4.8), in patients with proven absence of CAD, indicating that the impact of depressed EF on survival is not due to CAD.
(2) Dr Rahimtoola requests survival data in subsets with 5% EF. We have already indicated that separation of subsets with EF Յ25% (nϭ14) or EF 25% to 35% (nϭ29) was not justified, as their 10-year survival (46% versus 39%, Pϭ0.52) was similar. We suggest that this request be fulfilled in a large cooperative study, as placing 43 patients into multiple subgroups does not allow analysis of survival.
(3) Dr Rahimtoola requests combined event-free survival data. If we combine the end points (death, heart failure, and thromboembolism), the 5-year event free survival was 58Ϯ8% for the markedly low EF group, confirming that most patients enjoy reasonable event-free survival after aortic valve replacement despite markedly reduced preoperative EF.
(4) The concern regarding comparison of observed and expected survival of operative survivors is misplaced. Useful information regarding distribution of immediate and long-term postoperative risk can be gleaned from such a comparison. This type of comparative analysis using age-and sex-matched controls is well known to us and is recommended by our statistics colleagues. In AR, this analysis shows that excess risk attached to reduced left ventricular function is not just perioperative, but also long-term.
Despite the excess risk, many patients enjoy several years of event-free survival and thus should not be denied the benefits of aortic valve replacement.
